Top

Published in:

Open Access 01-12-2014 | Review

Component resolved diagnosis: when should it be used?

Authors: Olga Luengo, Victòria Cardona

Published in: Clinical and Translational Allergy | Issue 1/2014

Abstract

The knowledge on molecular allergy diagnosis is continuously evolving. It is now time for the clinician to integrate this knowledge and use it when needed to improve the accuracy of diagnosis and thus provide more precise therapeutic and avoidance measures. This review does not intend to comprehensively analyze all the available allergen molecules, but to provide some practical clues on use and interpretation of molecular allergy diagnosis. The potential role of component resolved diagnosis in circumstances such as the indication of allergen immunotherapy, pollen polysensitization, food allergy, latex allergy or anaphylaxis, is assessed. Interpreting the information provided by molecular allergy diagnosis needs a structured approach. It is necessary to evaluate single positivities and negativities, but also to appraise “the big picture” with perspective.

Available only for authorised users

Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy. 1999, 29: 896-904. 10.1046/j.1365-2222.1999.00653.x.CrossRefPubMed

Sastre J: Molecular diagnosis in allergy. Clin Exp Allergy. 2010, 40: 1442-1460. 10.1111/j.1365-2222.2010.03585.x.CrossRefPubMed

Treudler R, Simon JC: Overview of component resolved diagnostics. Curr Allergy Asthma Rep. 2013, 13: 110-117. 10.1007/s11882-012-0318-8.CrossRefPubMed

Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, Melioli G, Nunes C, Passalacqua G, Rosenwasser L, Sampson H, Sastre J, Bousquet J, Zuberbier T: A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013, 6: 17-10.1186/1939-4551-6-17.PubMedCentralCrossRefPubMed

Barber D, De La Torre F, Feo F, Florido F, Guardia P, Moreno C, Quiralte J, Lombardero M, Villalba M, Salcedo G, Rodríguez R: Understanding patient sensitization profiles in complex pollen areas: a molecular epidemiological study. Allergy. 2008, 63: 1550-1558. 10.1111/j.1398-9995.2008.01807.x.CrossRefPubMed

Barber D, Moreno C, Ledesma A, Serrano P, Galán A, Villalba M, Guerra F, Lombardero M, Rodríguez R: Degree of olive pollen exposure and sensitization patterns. Clinical implications. J Investig Allergol Clin Immunol. 2007, 17 (Suppl 1): 11-16.PubMed

Nilsson OB, Van Hage M, Grönlund H: Mammalian-derived respiratory allergens - Implications for diagnosis and therapy of individuals allergic to furry animals. Methods. 2014, 66: 86-95. 10.1016/j.ymeth.2013.09.002.CrossRefPubMed

Mattsson L, Lundgren T, Everberg H, Larsson HH, Lidholm J: Prostatic kallikrein: a new major dog allergen. J Allergy Clin Immunol. 2009, 123: 362-368. 10.1016/j.jaci.2008.11.021.CrossRefPubMed

Basagaña M, Luengo O, Labrador-Horrillo M, Garriga T, Mattsson L, Lidholm J, Cardona V: Component resolved diagnosis of dog allergy. Allergy. 2010, 65 (Suppl. 92): 683A-

10.

Curin M, Reininger R, Swoboda I, Focke M, Valenta R, Spitzauer S: Skin prick test extracts for dog allergy diagnosis show considerable variations regarding the content of major and minor dog allergens. Int Arch Allergy Immunol. 2011, 154: 258-263. 10.1159/000321113.CrossRefPubMed

11.

Migueres M, Dávila I, Frati F, Azpeitia A, Jeanpetit Y, Lhéritier-barrand M: Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease. Clin Transl Allergy. 2014, 4: 16-10.1186/2045-7022-4-16.PubMedCentralCrossRefPubMed

12.

Bousquet PJ, Castelli C, Daures JP, Heinrich J, Hooper R, Sunyer J, Wjst M, Jarvis D, Burney P: Assessment of allergen sensitization in a general population-based survey (European Community Respiratory Health Survey I). Ann Epidemiol. 2010, 20: 797-803. 10.1016/j.annepidem.2010.05.012.CrossRefPubMed

13.

Calderón MA, Cox L, Casale TB, Moingeon P, Demoly P: Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol. 2012, 129: 929-934. 10.1016/j.jaci.2011.11.019.CrossRefPubMed

14.

Passalacqua G: The use of single versus multiple antigens in specific allergen immunotherapy for allergic rhinitis: review of the evidence. Curr Opin Allergy Clin Immunol. 2014, 14: 20-24. 10.1097/ACI.0000000000000018.CrossRefPubMed

15.

Valenta R, Twaroch T, Swoboda I: Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. J Investig Allergol Clin Immunol. 2007, 17 (Suppl 1): 36-40.PubMed

16.

Sastre J, Landivar ME, Ruiz-García M, Andregnette-Rosigno MV, Mahillo I: How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012, 67: 709-711. 10.1111/j.1398-9995.2012.02808.x.CrossRefPubMed

17.

Letrán A, Espinazo M, Moreno F: Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy. Ann Allergy Asthma Immunol. 2013, 111: 295-297. 10.1016/j.anai.2013.07.005.CrossRefPubMed

18.

Stringari G, Tripodi S, Caffarelli C, Dondi A, Asero R, Di Rienzo Businco A, Bianchi A, Candelotti P, Ricci G, Bellini F, Maiello N, Miraglia Del Giudice M, Frediani T, Sodano S, Dello Iacono I, Macrì F, Peparini I, Povesi Dascola C, Patria MF, Varin E, Peroni D, Comberiati P, Chini L, Moschese V, Lucarelli S, Bernardini R, Pingitore G, Pelosi U, Tosca M, Cirisano A: The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol. 2014, 134: 75-81. 10.1016/j.jaci.2014.01.042.CrossRefPubMed

19.

Tripodi S, Frediani T, Lucarelli S, MacR F, Pingitore G, Di Rienzo Businco A, Dondi A, Pansa P, Ragusa G, Asero R, Faggian D, Plebani M, Matricardi PM: Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapy. J Allergy Clin Immunol. 2012, 129: 834-839. 10.1016/j.jaci.2011.10.045.CrossRefPubMed

20.

Darsow U, Brockow K, Pfab F, Jakob T, Petersson CJ, Borres MP, Ring J, Behrendt H, Huss-Marp J: Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy–implications for immunotherapy?. Clin Exp Allergy. 2014, 44: 778-786. 10.1111/cea.12303.CrossRefPubMed

21.

Douladiris N, Savvatianos S, Roumpedaki I, Skevaki C, Mitsias D, Papadopoulos NG: A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases. Int Arch Allergy Immunol. 2013, 162: 163-172. 10.1159/000353113.CrossRefPubMed

22.

Monsalve RI, Vega A, Marqués L, Miranda A, Fernández J, Soriano V, Cruz S, Domínguez-Noche C, Sánchez-Morillas L, Armisen-Gil M, Guspí R, Barber D: Component-resolved diagnosis of vespid venom-allergic individuals: Phospholipases and antigen 5 s are necessary to identify Vespula or Polistes sensitization. Allergy. 2012, 67: 528-536. 10.1111/j.1398-9995.2011.02781.x.CrossRefPubMed

23.

Ebo DG, Faber M, Sabato V, Leysen J, Bridts CH, De Clerck LS: Component-resolved diagnosis of wasp (yellow jacket) venom allergy. Clin Exp Allergy. 2013, 43: 255-261. 10.1111/cea.12057.CrossRefPubMed

24.

Müller U, Schmid-Grendelmeier P, Hausmann O, Helbling A: IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy. Allergy. 2012, 67: 1069-1073. 10.1111/j.1398-9995.2012.02847.x.CrossRefPubMed

25.

Sturm GJ, Biló MB, Bonadonna P, Hemmer W, Caruso B, Bokanovic D, Aberer W: Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north–south difference in Api m 1 sensitization in Europe. J Allergy Clin Immunol. 2012, 130: 817-10.1016/j.jaci.2012.05.047.CrossRefPubMed

26.

Köhler J, Blank S, Müller S, Bantleon F, Frick M, Huss-Marp J, Lidholm J, Spillner E, Jakob T: Component resolution reveals additional major allergens in patients with honeybee venom allergy. J Allergy Clin Immunol. 2014, 133: 1383-1389. 10.1016/j.jaci.2013.10.060.CrossRefPubMed

27.

Wölbing F, Biedermann T: Anaphylaxis: Opportunities of stratified medicine for diagnosis and risk assessment. Allergy. 2013, 68: 1499-1508. 10.1111/all.12322.CrossRefPubMed

28.

Cardona V, Luengo O, Garriga T, Labrador-Horrillo M, Sala-Cunill A, Izquierdo A, Soto L, Guilarte M: Co-factor-enhanced food allergy. Allergy. 2012, 67: 1316-1318. 10.1111/j.1398-9995.2012.02877.x..CrossRefPubMed

29.

Romano A, Scala E, Rumi G, Gaeta F, Caruso C, Alonzi C, Maggioletti M, Ferrara R, Palazzo P, Palmieri V, Zeppilli P, Mari A: Lipid transfer proteins: the most frequent sensitizer in Italian subjects with food-dependent exercise-induced anaphylaxis. Clin Exp Allergy. 2012, 42: 1643-1653. 10.1111/cea.12011.CrossRefPubMed

30.

Pastorello EA, Farioli L, Stafylaraki C, Scibilia J, Mirone C, Pravettoni V, Ottolenghi AI, Conio S, Mascheri A, Losappio L, Capocchi A, Fontanini D, De Giacomo C: Wheat-dependent exercise-induced anaphylaxis caused by a lipid transfer protein and not by ω-5 gliadin. Ann Allergy Asthma Immunol. 2014, 112: 386-387. 10.1016/j.anai.2014.01.012. e1CrossRefPubMed

31.

Commins SP, Platts-Mills TA: Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol. 2009, 124: 652-657. 10.1016/j.jaci.2009.08.026.PubMedCentralCrossRefPubMed

32.

Tripathi A, Commins SP, Heymann PW, Platts-Mills TA: Delayed anaphylaxis to red meat masquerading as idiopathic anaphylaxis. J Allergy Clin Immunol Pract. 2014, 2: 259-265. 10.1016/j.jaip.2014.02.017.PubMedCentralCrossRefPubMed

33.

Berg EA, Platts-Mills TA, Commins SP: Drug allergens and food-the cetuximab and galactose-alpha-1,3-galactose story. Ann Allergy Asthma Immunol. 2014, 112: 97-101. 10.1016/j.anai.2013.11.014.PubMedCentralCrossRefPubMed

34.

Heaps A, Carter S, Selwood C, Moody M, Unsworth J, Deacock S, Sumar N, Bansal A, Hayman G, El-Shanawany T, Williams P, Kaminski E, Jolles S: The utility of the ISAC Allergen Array in the investigation of Idiopathic Anaphylaxis. Clin Exp Immunol. 2014, 177: 483-490. 10.1111/cei.12334.PubMedCentralCrossRefPubMed

35.

Ott H, Schröder C, Raulf-Heimsoth M, Mahler V, Ocklenburg C, Merk HF, Baron JM: Microarrays of recombinant Hevea brasiliensis proteins: a novel tool for the component-resolved diagnosis of natural rubber latex allergy. J Investig Allergol Clin Immunol. 2010, 20: 129-138.PubMed

36.

Ebo DG, Hagendorens MM, De Knop KJ, Verweij MM, Bridts CH, De Clerck LS, Stevens WJ: Component-resolved diagnosis from latex allergy by microarray. Clin Exp Allergy. 2010, 40: 348-358. 10.1111/j.1365-2222.2009.03370.x.CrossRefPubMed

37.

Schuler S, Ferrari G, Schmid-Grendelmeier P, Harr T: Microarray-based component-resolved diagnosis of latex allergy: isolated IgE-mediated sensitization to latexprofilin Hev b8 may act as confounder. Clin Transl Allergy. 2013, 3: 11-10.1186/2045-7022-3-11.PubMedCentralCrossRefPubMed

38.

Haeberle HA, Lupic D, Midoro-Horiuti T, Kiefer RT, Schroeder TH, Unertl K, Dieterich HJ: Role of cross-allergies to latex in clinical routine of anesthesia. J Clin Anesth. 2003, 15: 495-504. 10.1016/S0952-8180(03)00112-0.CrossRefPubMed

39.

Quercia O, Stefanini GF, Scardovi A, Asero R: Patients monosensitised to Hev b 8 (Hevea brasiliensis latex profilin) may safely undergo major surgery in a normal (non-latex safe) environment. Eur Ann Allergy Clin Immunol. 2009, 41: 112-116.PubMed

40.

Mahler V, Gutgesell C, Valenta R, Fuchs T: Natural rubber latex and hymenoptera venoms share ImmunoglobinE-epitopes accounting for cross-reactive carbohydrate determinants. Clin Exp Allergy. 2006, 36: 1446-1456. 10.1111/j.1365-2222.2006.02587.x.CrossRefPubMed

41.

Passalacqua G, Melioli G, Bonifazi F, Bonini S, Maggi E, Senna G, Triggiani M, Nettis E, Rossi RE, Vacca A, Canonica GW: The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy. 2013, 68: 1029-1033. 10.1111/all.12194.CrossRefPubMed

42.

Nilsson OB, Binnmyr J, Zoltowska A, Saarne T, Van Hage M, Grönlund H: Characterization of the dog lipocalin allergen Can f 6: the role in cross-reactivity with cat and horse. Allergy Eur J Allergy Clin Immunol. 2012, 67: 751-757. 10.1111/j.1398-9995.2012.02826.x.CrossRef

43.

Jakob T, Hilger C, Hentges F: Clinical relevance of sensitization to cross-reactive lipocalin Can f 6. Allergy. 2013, 68: 690-691. 10.1111/all.12107.CrossRefPubMed

44.

Posthumus J, James HR, Lane CJ, Matos LA, Platts-Mills TAE, Commins SP: Initial description of pork-cat syndrome in the United States. J Allergy Clin Immunol. 2013, 131: 923-925. 10.1016/j.jaci.2012.12.665.PubMedCentralCrossRefPubMed

45.

Katelaris CH: Food allergy and oral allergy or pollen-food syndrome. Curr Opin Allergy Clin Immunol. 2010, 10: 246-251. 10.1097/ACI.0b013e32833973fb.CrossRefPubMed

46.

Ebo DG, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ: Sensitization to cross-reactive carbohydrate determinants and the ubiquitous protein profilin: Mimickers of allergy. Clin Exp Allergy. 2004, 34: 137-144. 10.1111/j.1365-2222.2004.01837.x.CrossRefPubMed

47.

Villalta D, Conte M, Asero R, Da Re M, Stella S, Martelli P: Isolated IgE reactivity to native walnut vicilin-like protein (nJug r 2) on ISAC microarray is due to cross-reactive carbohydrate epitopes. Clin Chem Lab Med. 2013, 51: 1991-1995.CrossRefPubMed

48.

Fernández-Rivas M, Bolhaar S, González-Mancebo E, Asero R, van Leeuwen A, Bohle B, Ma Y, Ebner C, Rigby N, Sancho AI, Miles S, Zuidmeer L, Knulst A, Breiteneder H, Mills C, Hoffmann-Sommergruber K, van Ree R: Apple allergy across Europe: How allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol. 2006, 118: 481-488. 10.1016/j.jaci.2006.05.012.CrossRefPubMed

49.

Pascal M, Muñoz-Cano R, Reina Z, Palacín A, Vilella R, Picado C, Juan M, Sánchez-López J, Rueda M, Salcedo G, Valero A, Yagüe J, Bartra J, Palacı A: Lipid transfer protein syndrome: Clinical pattern, cofactor effect and profile of molecular sensitization to plant-foods and pollens. Clin Exp Allergy. 2012, 42: 1529-1539. 10.1111/j.1365-2222.2012.04071.x.CrossRefPubMed

50.

Soto L, Luengo O, Labrador-Horrillo M, Sala-Cunill A, Guilarte M, Cardona V: Recognition pattern to individual allergens in pollen allergic patients sensitised to lipid transfer proteins. Allergy. 2012, 67 (Suppl. 96): 541A-

51.

Asero R, Pravettoni V: Anaphylaxis to plant-foods and pollen allergens in patients with lipid transfer protein syndrome. Curr Opin Allergy Clin Immunol. 2013, 13: 379-385. 10.1097/ACI.0b013e32835f5b07.CrossRefPubMed

52.

Röseler S, Balakirski G, Plange J, Wurpts G, Baron JM, Megahed M, Merk HF: Anaphylaxis to PR-10 proteins (Bet v1 homologues). Hautarzt. 2013, 64: 890-892. 10.1007/s00105-013-2683-1.CrossRefPubMed

53.

Berneder M, Bublin M, Hoffmann-Sommergruber K, Hawranek T, Lang R: Allergen chip diagnosis for soy-allergic patients: Gly m 4 as a marker for severe food-allergic reactions to soy. Int Arch Allergy Immunol. 2013, 161: 229-233. 10.1159/000345970.CrossRefPubMed

54.

Nicolaou N, Custovic A: Molecular diagnosis of peanut and legume allergy. Curr Opin Allergy Clin Immunol. 2011, 11: 222-228. 10.1097/ACI.0b013e32834656c2.CrossRefPubMed

55.

Klemans RJB, Otte D, Knol M, Knol EF, Meijer Y, Gmelig-Meyling FHJ, Bruijnzeel-Koomen CAFM, Knulst AC, Pasmans SGMA: The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model. J Allergy Clin Immunol. 2013, 131: 157-163. 10.1016/j.jaci.2012.08.010.CrossRefPubMed

56.

Sicherer SH, Sampson HA: Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014, 133: 291-307. 10.1016/j.jaci.2013.11.020.CrossRefPubMed

57.

Masthoff LJN, Mattsson L, Zuidmeer-Jongejan L, Lidholm J, Andersson K, Akkerdaas JH, Versteeg SA, Garino C, Meijer Y, Kentie P, Versluis A, Den Hartog Jager CF, Bruijnzeel-Koomen CAFM, Knulst AC, Van Ree R, Van Hoffen E, Pasmans SGMA: Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. J Allergy Clin Immunol. 2013, 132: 393-399. 10.1016/j.jaci.2013.02.024.CrossRefPubMed

58.

Holzhauser T, Wackermann O, Ballmer-Weber BK, Bindslev-Jensen C, Scibilia J, Perono-Garoffo L, Utsumi S, Poulsen LK, Vieths S: Soybean (Glycine max) allergy in Europe: Gly m 5 (beta-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy. J Allergy Clin Immunol. 2009, 123: 452-458. 10.1016/j.jaci.2008.09.034.CrossRefPubMed

59.

Bublin M, Breiteneder H: Cross-Reactivity of Peanut Allergens. Curr Allergy Asthma Rep. 2014, 14: 426-PubMedCentralCrossRefPubMed

60.

Egger M, Hauser M, Mari A, Ferreira F, Gadermaier G: The role of lipid transfer proteins in allergic diseases. Curr Allergy Asthma Rep. 2010, 10: 326-335. 10.1007/s11882-010-0128-9.CrossRefPubMed

61.

Palacín A, Rivas LA, Gómez-Casado C, Aguirre J, Tordesillas L, Bartra J, Blanco C, Carrillo T, Cuesta-Herranz J, Bonny JAC, Flores E, García-Alvarez-Eire MG, García-Nuñez I, Fernández FJ, Gamboa P, Muñoz R, Sánchez-Monge R, Torres M, Losada SV, Villalba M, Vega F, Parro V, Blanca M, Salcedo G, Díaz-Perales A: The involvement of thaumatin-like proteins in plant food cross-reactivity: a multicenter study using a specific protein microarray. PLoS One. 2012, 7: e44088-10.1371/journal.pone.0044088.PubMedCentralCrossRefPubMed

Title: Component resolved diagnosis: when should it be used?
Authors: Olga Luengo
Victòria Cardona
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Clinical and Translational Allergy / Issue 1/2014
Electronic ISSN: 2045-7022
DOI: https://doi.org/10.1186/2045-7022-4-28

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Component resolved diagnosis: when should it be used?

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Schnitzler’s syndrome: lessons from 281 cases

Allergic sensitization: food- and protein-related factors

Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: an Allergists’ Consensus

Characterisation of interleukin-10 expression on different vascular structures in allergic nasal mucosa

An EAACI “European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)”: the methodology

Standardized food challenges are subject to variability in interpretation of clinical symptoms